Kelly Bliss - Feb 28, 2025 Form 4 Insider Report for Teladoc Health, Inc. (TDOC)

Role
President, U.S. Group Health
Signature
/s/ Adam C. Vandervoort, Attorney-in-Fact
Stock symbol
TDOC
Transactions as of
Feb 28, 2025
Transactions value $
-$28,122
Form type
4
Date filed
3/4/2025, 04:06 PM
Previous filing
Dec 3, 2024
Next filing
Mar 21, 2025
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction TDOC Common Stock Options Exercise +1.4K +4.35% 33.6K Feb 28, 2025 Direct F1
transaction TDOC Common Stock Options Exercise +3.49K +10.37% 37.1K Feb 28, 2025 Direct F1
transaction TDOC Common Stock Options Exercise +1.19K +3.2% 38.3K Feb 28, 2025 Direct F2
transaction TDOC Common Stock Sale -$28.1K -2.9K -7.58% $9.68 35.4K Mar 3, 2025 Direct F3

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction TDOC Restricted Stock Units Options Exercise $0 -1.4K -100% $0.00 0 Feb 28, 2025 Common Stock 1.4K Direct F1, F4
transaction TDOC Restricted Stock Units Options Exercise $0 -3.49K -20% $0.00 14K Feb 28, 2025 Common Stock 3.49K Direct F1, F5
transaction TDOC Performance Stock Units Options Exercise $0 -1.19K -20.01% $0.00 4.75K Feb 28, 2025 Common Stock 1.19K Direct F2, F6
transaction TDOC Restricted Stock Units Award $0 +110K $0.00 110K Mar 1, 2025 Common Stock 110K Direct F7, F8
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Restricted stock units convert to shares of TDOC common stock on a one-for-one basis.
F2 Performance stock units convert to shares of TDOC common stock on a one-for-one basis.
F3 Shares sold to cover the tax withholding obligation in respect of vesting of the reporting person's performance stock unit and restricted stock unit awards.
F4 On March 1, 2022, the reporting person was granted 16,844 restricted stock units, vesting one-third on the first anniversary of the grant date, with the remainder vesting in eight substantially equal quarterly installments thereafter.
F5 On March 3, 2023, the reporting person was granted 41,853 restricted stock units, vesting one-third on March 1, 2024, with the remainder vesting in eight substantially equal quarterly installments thereafter.
F6 On March 1, 2024, the reporting person earned 14,263 performance stock units, vesting one-third on March 1, 2024, with the remainder vesting in eight substantially equal quarterly installments thereafter.
F7 Each restricted stock unit represents a contingent right to receive one share of TDOC common stock.
F8 One-third of the restricted stock units vest on the first anniversary of the grant date, with the remainder vesting in eight substantially equal quarterly installments thereafter.